Surgical Treatment of Complex Partial Seizures: 20 Years' ExperienceGarcia-Flores E.
Department of Neurosurgery, Centro Medico Osler, Monterrey, Mexico
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
From 1972 to 1992 inclusive, the author performed 263 surgical procedures for the relief of intractable epilepsy. The purpose of this report is to review 112 temporal lobectomies for the treatment of drug-resistant complex partial seizures. There were 90 adults and 22 children, in whom there were 61 left-sided procedures and 51 right-sided ones. All these cases represent 10% of 2,676 epileptics seen at the Osier Clinic during the last 20 years. The results were evaluated in four groups: 60 patients belonging to group A were seizure-free, group B comprised 24 patients with a reduction in seizures of 75%, group C which included 17 cases had minimal improvement, and finally group D with 11 patients showed no improvement at all. The factors of good surgical outcome were analyzed in 60 patients. The total number of patients that substantially improved after surgery represented 74.5% of the whole series with no mortality and a morbidity of 1.8%.
© 1994 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.